EUVIMEDEUVIMED entdecken
EditorialKommentarKohortenstudie

Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study

Tsunenori Kondo

International Journal of Urology · 2024

DOI: 10.1111/iju.15343 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Urology, 2024. Verfasst von Tsunenori Kondo. Beteiligte Einrichtung: Department of Urology, Tokyo Women's Medical University Adachi Medical Center, Adachi-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Kidney Neoplasms, Ureteral Neoplasms. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It has been reported that tumor location has an impact on the survival of patients with upper tract urothelial carcinoma (UTUC). Many studies have demonstrated that ureteral cancer has a worse prognosis than renal pelvic cancer, although there are some contrary results.1 One of the possible explanations for the worse outcome of ureteral cancer is that it includes an extensive plexus of blood vessels and lymphatic channels in the extra-ureteric fat, which promotes tumor invasion and metastasis.2 According to the latest tumor, node, and metastasis classification, pathological T stage 3 (pT3) ureteral cancer is defined as the invasion beyond muscularis into periureteric fat, and pT3 renal pelvic cancer is defined as the invasion beyond muscularis into peripelvic fat or renal parenchyma. Thus, patient prognosis may be differentiated between the patients with invasion to perirenal fat tissue or renal parenchyma in T3 renal pelvic cancer. The stratification according to the presence of surrounding fat tissue invasion may be helpful in selecting the patients for adjuvant chemotherapy. In the present study, the authors subclassified pT3 UTUC patients into two groups according to the infiltration to the surrounding adipose tissue.3 This criterion successfully stratified the patients with pT3 renal pelvic cancer. Those with invasion into renal parenchymal were defined as pT3a, and the renal pelvic or ureteral cancer patients with invasion to surrounding fat tissue was defined as pT3b. Patients with pT3a renal pelvic cancer showed a better recurrence-free and cancer-specific survival compared with those with pT3b renal pelvic or ureteral cancer. Interestingly, there was no difference in the oncological outcome of pT3b patients according to tumor location. I believe that the present study may allow for the better selection of patients for adjuvant therapy, especially in renal pelvic cancer patients. However, we should be aware of the report from Sassa et al. in which the extension of parenchymal invasion effectively classified the T3 renal pelvic cancer.4 Those with invasion into the renal cortex showed worse outcomes than those with invasion only into the renal medulla. Thus, not all T3a patients may show a favorable prognosis. Moreover, our study has shown that lymphadenectomy improved the survival of patients with upper or middle ureteral cancer, but not those with lower ureteral cancer.5 Thus, tumor location in the ureter may need to be considered. Nevertheless, subclassification of pT3 UTUC is crucial to predict patient survival more accurately. This can also be used to better select patients who are fit for adjuvant chemotherapy. I believe that the extension of tumor invasion as shown in the present study is practical; however, novel classification models incorporating other pathological factors or biomarkers are warranted. Tsunenori Kondo received honoraria from Pfizer, MSD, Takeda Pharmaceutical Company, and Ono Pharmaceutical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Transitional CellKidney NeoplasmsUreteral NeoplasmsHumansPrognosisCohort StudiesRetrospective StudiesMulticenter Studies as Topic

Autor:innen und Institutionen

  • Department of Urology, Tokyo Women's Medical University Adachi Medical Center, Adachi-ku, Tokyo, Japan.

Zitieren

APA

Kondo, T. (2024). Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study. International Journal of Urology. https://doi.org/10.1111/iju.15343

Vancouver

Kondo T. Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study. International Journal of Urology. 2024. doi:10.1111/iju.15343

BibTeX
@article{Kondo2024,
  author = {Kondo, Tsunenori},
  title = {Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15343}
}
Kostenlos starten →